| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Aberrant oestrogen receptor species in human meningioma tissue
|
Koehorst, S.G.A.
|
|
1992
|
43 |
1-3 |
p. 57-61
5 p.
|
artikel
|
| 2 |
Abnormal estrogen receptor in clinical breast cancer
|
McGuire, William L.
|
|
1992
|
43 |
1-3 |
p. 243-247
5 p.
|
artikel
|
| 3 |
ACTH/MSH like peptides in the treatment of cisplatin neuropathy
|
Gispen, W.H.
|
|
1992
|
43 |
1-3 |
p. 179-183
5 p.
|
artikel
|
| 4 |
Androgen sensitivity and gene expression in ras + myc-induced mouse prostate carcinomas
|
Thompson, Timothy C.
|
|
1992
|
43 |
1-3 |
p. 79-85
7 p.
|
artikel
|
| 5 |
Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients
|
Dowsett, M.
|
|
1992
|
43 |
1-3 |
p. 155-159
5 p.
|
artikel
|
| 6 |
Basic fibroblast growth factor (bFGF): Mitogenic activity and binding sites in human breast cancer
|
Peyrat, J.-Ph.
|
|
1992
|
43 |
1-3 |
p. 87-94
8 p.
|
artikel
|
| 7 |
Clinical breast cancer, new developments in selection and endocrine treatment of patients
|
Klijn, J.G.M.
|
|
1992
|
43 |
1-3 |
p. 211-221
11 p.
|
artikel
|
| 8 |
Diminution of antibodies directed against tumor cell surface epitopes: A single chain Fv fusion molecule specifically recognizes the extracellular domain of the c-erbB-2 receptor
|
Wels, W.
|
|
1992
|
43 |
1-3 |
p. 1-7
7 p.
|
artikel
|
| 9 |
Direct stimulation by estrogen of growth factor signal transduction pathways in human breast cancer cells
|
van der Burg, Bart
|
|
1992
|
43 |
1-3 |
p. 111-115
5 p.
|
artikel
|
| 10 |
Domain functions of the androgen receptor
|
Simental, Jorge A.
|
|
1992
|
43 |
1-3 |
p. 37-41
5 p.
|
artikel
|
| 11 |
Editorial Board
|
|
|
1992
|
43 |
1-3 |
p. IFC-
1 p.
|
artikel
|
| 12 |
Exemestane (FCE 24304), A new steroidal aromatase inhibitor
|
di Salle, E.
|
|
1992
|
43 |
1-3 |
p. 137-143
7 p.
|
artikel
|
| 13 |
Experimental studies with liarozole (R 75 251): An antitumoral agent which inhibits retinoic acid breakdown
|
De Coster, R.
|
|
1992
|
43 |
1-3 |
p. 197-201
5 p.
|
artikel
|
| 14 |
Fadrozole hydrochloride, a new nontoxic aromatase inhibitor for the treatment of patients with metastatic breast cancer
|
Falkson, Geoffrey
|
|
1992
|
43 |
1-3 |
p. 161-165
5 p.
|
artikel
|
| 15 |
Growth factors in breast cancer: Mitogenesis to transformation
|
Dickson, Robert B.
|
|
1992
|
43 |
1-3 |
p. 69-78
10 p.
|
artikel
|
| 16 |
High frequency of mammary adenocarcinomas in metallothionein promoter-human growth hormone transgenic mice created from two different strains of mice
|
Törnell, Jan
|
|
1992
|
43 |
1-3 |
p. 237-242
6 p.
|
artikel
|
| 17 |
Hormonal regulation of c-erbB-2 oncogene expression in breast cancer cells
|
De Bortoli, M.
|
|
1992
|
43 |
1-3 |
p. 21-25
5 p.
|
artikel
|
| 18 |
4-Hydroxyandrostenedione treatment for postmenopausal patients with breast cancer
|
Coombes, R.C.
|
|
1992
|
43 |
1-3 |
p. 145-148
4 p.
|
artikel
|
| 19 |
Hypercalcemia in cancer
|
Martin, T.J.
|
|
1992
|
43 |
1-3 |
p. 123-129
7 p.
|
artikel
|
| 20 |
ICI 182,780, a new antioestrogen with clinical potential
|
Wakeling, Alan E.
|
|
1992
|
43 |
1-3 |
p. 173-177
5 p.
|
artikel
|
| 21 |
Inhibition of oestrogen synthesis in postmenopausal women with breast cancer
|
James, V.H.T.
|
|
1992
|
43 |
1-3 |
p. 149-153
5 p.
|
artikel
|
| 22 |
Mechanisms of growth inhibition by antiestrogens and progestins in human breast and endometrial cancer cells
|
Murphy, L.C.
|
|
1992
|
43 |
1-3 |
p. 117-121
5 p.
|
artikel
|
| 23 |
Modulation of the agonist activity of antisteroids by a novel cis-acting element
|
Stoney Simons Jr., S.
|
|
1992
|
43 |
1-3 |
p. 43-55
13 p.
|
artikel
|
| 24 |
Modulation of tumour-induced bone resorption by bisphosphonates
|
Papapoulos, Socrates E.
|
|
1992
|
43 |
1-3 |
p. 131-136
6 p.
|
artikel
|
| 25 |
Novel antitumor peptide hormones and their effect on signal transduction
|
Kéri, Gy.
|
|
1992
|
43 |
1-3 |
p. 105-110
6 p.
|
artikel
|
| 26 |
Preface
|
|
|
1992
|
43 |
1-3 |
p. vii-
1 p.
|
artikel
|
| 27 |
Progestin-induced fatty acid synthetase in human mammary tumors: From molecular to clinical studies
|
Chalbos, D.
|
|
1992
|
43 |
1-3 |
p. 223-228
6 p.
|
artikel
|
| 28 |
Prognostic factors in human primary breast cancer: Comparison of c-myc and HER2/neu amplification
|
Berns, E.M.J.J.
|
|
1992
|
43 |
1-3 |
p. 13-19
7 p.
|
artikel
|
| 29 |
Signal transduction by the neu/ebrB-2 receptor: A potential target for anti-tumor therapy
|
Stancovski, Ilana
|
|
1992
|
43 |
1-3 |
p. 95-103
9 p.
|
artikel
|
| 30 |
Somatostatin receptor imaging in the diagnosis and treatment of neuroendocrine tumors
|
Lamberts, S.W.J.
|
|
1992
|
43 |
1-3 |
p. 185-188
4 p.
|
artikel
|
| 31 |
Somatostatin receptors in human cancer: Incidence, characteristics, functional correlates and clinical implications
|
Reubi, J.C.
|
|
1992
|
43 |
1-3 |
p. 27-35
9 p.
|
artikel
|
| 32 |
Steroids and growth promoting factors in the regulation of expression of genes and gene networks
|
Cato, A.C.B.
|
|
1992
|
43 |
1-3 |
p. 63-68
6 p.
|
artikel
|
| 33 |
Tamoxifen induced changes in MCF7 human breast cancer: In vitro and in vivo studies using nuclear magnetic resonance spectroscopy and imaging
|
Furman, E.
|
|
1992
|
43 |
1-3 |
p. 189-195
7 p.
|
artikel
|
| 34 |
The antitumor potency of progesterone antagonists is due to their differentiation potential
|
Michna, Horst
|
|
1992
|
43 |
1-3 |
p. 203-210
8 p.
|
artikel
|
| 35 |
The role of erbB-2 and its ligands in growth control of malignant breast epithelium
|
Lupu, Ruth
|
|
1992
|
43 |
1-3 |
p. 229-236
8 p.
|
artikel
|
| 36 |
The Wnt gene family in tumorigenesis and in normal development
|
Nusse, Roel
|
|
1992
|
43 |
1-3 |
p. 9-12
4 p.
|
artikel
|
| 37 |
Tissue androgens and the endocrine autonomy of breast cancer
|
Blankenstein, M.A.
|
|
1992
|
43 |
1-3 |
p. 167-171
5 p.
|
artikel
|
Tijdschrift beschrijving